A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
‘Conservative’ King Review response
Health Minister Greg Hunt hints at no major shake-up, but trade-offs will be made.
Attempting to allay fears of a major pharmacy sector shake-up, the...
Aged care residents deserve better
Pharmacists should be embedded in aged care facilities nationwide.
The health of the aged care sector matters a great deal to PSA and the...
An opportunity for better aged care
The past 2 months have laid bare fundamental problems in Australia’s residential aged care facilities as COVID-19 ripped through more than 100 Melbourne nursing...
Digital presence for remote community pharmacies
I own a remote community pharmacy in WA. Is there a need for my pharmacy to have a digital or online presence?
In the 20th...
Aged care royal commission welcomed by pharmacist sector
Following distressing reports of inappropriate medicine use in aged care homes, PSA National President Dr Shane Jackson has welcomed a royal commission into the...
